Pharos Capital launches Verdi Oncology, an oncology practice and clinical research management platform
2018-03-19
DALLAS & NASHVILLE, Tennessee – (COMMERCIAL THREAD) – Pharos Capital Group, LLC (“Pharos”), a Dallas and Nashville-based private equity firm, announced the acquisition of Horizon Oncology (“Horizon”), headquartered in Lafayette, in Indiana. The acquisition marks the launch of Verdi Oncology, Inc. (“Verdi”), an oncology and clinical research practice management company.Read More →